| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
IMPEDIMED LIMITED (IPD)
Stock Code: IPD
Listing Date: 2007-10-24 00:00:00
Website: http://www.impedimed.com
Industry: Health Care Equipment & Services
Principal Activities:
The development and sale internationally of medical devices for diagnosing and monitoring human disorders and diseases.
Address:
50 Parker Court, Unit 1
PINKENBA
QLD 4008
Phone: (07) 3860 3700
Fax: (07) 3260 1225
Executives & Directors
Mr Melvyn, Mel John Bridges
Mr Greg Brown, Managing Director, CEO
Mr Martin Kriewaldt, Director, Non Exec. Director
Dr Cherrell Hirst, Director, Non Exec. Director
Mr James, Jim Hazel
Dr Michael Panaccio, Director, Non Exec. Director
Mr Phillip Stephen Auckland, CFO, Chief Op. Officer
Mr Steve Smith, Investor Relations
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
IPD - Annual General Meeting Overview and Operations Update - Mr Greg Brown, CEO and MD
|
|
Thu, 13 Nov 2008 10:45AM |
|
IPD - Quarterly Activities Update - Mr Greg Brown, CEO and MD
|
|
Fri, 1 Aug 2008 01:00PM |
|
IPD - Company Update from US - Mr Greg Brown, CEO and MD
|
|
Mon, 5 May 2008 03:30PM |
|
IPD - Completes US Acquisition of Xitron Technologies - Mr Greg Brown, CEO and MD
|
|
Tue, 30 Oct 2007 09:30AM |
| Annual General Meeting | Fri, 31 Oct 2008 12:00PM |
|
| Full Year Results | Fri, 29 Aug 2008 | |
| EGM | Mon, 21 Apr 2008 04:00PM |
|
| EGM | Mon, 21 Apr 2008 04:00PM |
|
| Interim Results | Tue, 26 Feb 2008 |
IMPEDIMED LIMITED (IPD)
| Third Year in Deloitte Fast 50 | Fri, 21 Nov 2008 |
| Appendix 3B - Quotation of Xitron consideration shares | Thu, 20 Nov 2008 |
| NSW BCI Adopts L-Dex technology | Tue, 18 Nov 2008 |
| Chosen for Australian Innovation Shootout in US | Fri, 14 Nov 2008 |
| Announcement of AGM Voting Results | Fri, 31 Oct 2008 |
| AGM Presentation - Confirms Growth Prospects | Fri, 31 Oct 2008 |
| Appendix 4C - Quarter Ended 30th Sep 2008 | Fri, 31 Oct 2008 |
| FDA Clearance of L-Dex U400 | Thu, 16 Oct 2008 |
| Article on effective ways of managing lymphedema publishes | Tue, 7 Oct 2008 |
| Know Your L-Dex Awareness Campaign launches in Houston Texas | Mon, 6 Oct 2008 |
| Escrow Release - Consideration Shares for Xitron Acquisition | Mon, 6 Oct 2008 |
| Announces agreement with Metagenics, Inc | Fri, 3 Oct 2008 |
| Annual Report 2008 | Mon, 29 Sep 2008 |
| Sample Proxy Form - Annual General Meeting | Mon, 29 Sep 2008 |
| Notice of Annual General Meeting | Mon, 29 Sep 2008 |
| Appendix 4E period ended 30 June 2008 | Fri, 29 Aug 2008 |
| Financial Results Announcement period ended 30 June 2008 | Fri, 29 Aug 2008 |
| Financial Report period ended 30 June 2008 | Fri, 29 Aug 2008 |
| Boardroom Radio Interview with CEO Greg Brown | Mon, 4 Aug 2008 |
| Change of Registered Office | Mon, 4 Aug 2008 |
| ImpediMed change of premises and contact details | Mon, 4 Aug 2008 |
| Change in substantial holding | Thu, 31 Jul 2008 |
| Cleansing Notice - Sec 708A(5)(e) | Wed, 30 Jul 2008 |
| Increases Capital Raising from 1.2M to 4.2M for US Mkt Expan | Wed, 30 Jul 2008 |
| Appendix 3B - Raising $3.0M | Wed, 30 Jul 2008 |
| Appendix 4C - quarterly 30th June 2008 | Wed, 30 Jul 2008 |
| ATO Class Ruling regarding Oct 2006 Demerger | Fri, 25 Jul 2008 |
| New Aust study - lymphoedema - public health issue deserving | Wed, 23 Jul 2008 |
| Change in substantial holding | Mon, 14 Jul 2008 |
| Cleansing Notice - Sec 708A(5)(e) | Fri, 11 Jul 2008 |
| Appendix 3B - Placement | Fri, 11 Jul 2008 |
| Share Placement / Raising | Fri, 11 Jul 2008 |
| Appendix 3B - Share and Option Plans Issue | Thu, 3 Jul 2008 |
| Premier Bligh opens ImpediMed`s US headquarters | Wed, 18 Jun 2008 |
| Aust Study - BIS most direct diagnostic tool for Lymphoedema | Thu, 12 Jun 2008 |
| Bioimpedance acknowledged in Irish Lymphoedema Guidelines | Wed, 21 May 2008 |
| Boardroom Radio interview with ImpediMed CEO | Tue, 6 May 2008 |
| Change in substantial holding - Deemed Escrow Ints Starfish | Fri, 2 May 2008 |
| Change of Director`s Interest Notice - Michael Panaccio | Fri, 2 May 2008 |
| Data show Preop Assessment of BC Patients enables early diag | Thu, 1 May 2008 |
| Change in substantial holding - Escrow impact on deemed int | Wed, 30 Apr 2008 |
| Appendix 4C - quarterly - Qtr ended 31st Mar 2008 | Wed, 30 Apr 2008 |
| Appendix 3B - Share Issue Acquisition Milestone 1 | Wed, 30 Apr 2008 |
| New Clinical Data and American Soc of Breast Surgeons Conf | Mon, 28 Apr 2008 |
| Results of Extraordinary General Meeting | Mon, 21 Apr 2008 |
| EGM Presentation - Executes plans to support US roll out | Mon, 21 Apr 2008 |
| Release of shares from voluntary escrow | Fri, 18 Apr 2008 |
| Resignation of Second Company Secretary | Wed, 9 Apr 2008 |
| Lodges FDA Application to Clinically Assess Lymphoedema (Arm | Tue, 8 Apr 2008 |
| Change of Director`s Interest Notice - Mel Bridges | Thu, 27 Mar 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.